Doctor profile · Federal record
Dr. WESLEIGH EDWARDS, MD, PHD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hospitalist Physician · SAN DIEGO, CA
- NPI 1205362258
- Accepts Medicare
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4044 FIFTH AVE
SAN DIEGO, CA 921032106
(619) 849-4469
fax (619) 849-1547 - Mailing address
-
10790 RANCHO BERNARDO RD
SAN DIEGO, CA 921275705
Credentials & registration
- NPI registered
- May 2017 — 9 yrs on file
- Profile last updated
- August 13, 2024
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A160951
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1205362258. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
22,052
Distinct HCPCS
10
Medicare allowed
$191,528
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9267 |
Injection, paclitaxel, 1 mg | 9,526 | 12 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 7,020 | 18 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,520 | 35 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,255 | 40 | $0 | |
J9045 |
Injection, carboplatin, 50 mg | 471 | 17 | $2 | |
96375 |
Injection of additional new drug or substance into vein | 458 | 56 | $17 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 258 | 49 | $189 | |
J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 216 | 13 | $96 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 211 | 80 | $150 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 163 | 47 | $137 |
In context: peer comparison
Among 34 peers in this city , average services per provider: 650. This provider delivers 34× the peer median.Open Payments
Industry payments received
All-time total
$448
Transactions
19
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SpringWorks Therapeutics, Inc. | 3 | $72.06 | |
| Novartis Pharmaceuticals Corporation | 3 | $69.71 | |
| Eisai Inc. | 2 | $50.77 | |
| GlaxoSmithKline, LLC. | 2 | $50.10 | |
| ABBVIE INC. | 2 | $42.50 | |
| AstraZeneca Pharmaceuticals LP | 2 | $38.32 | |
| Blueprint Medicines Corporation | 1 | $29.71 | |
| Merck Sharp & Dohme LLC | 1 | $27.44 | |
| PFIZER INC. | 1 | $24.90 | |
| Aadi Bioscience, Inc. | 1 | $24.18 | |
| Daiichi Sankyo Inc. | 1 | $18.61 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
336
Patients
128
Total drug cost
$6,932
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 93 | 42 | $1,246 |
| Prochlorperazine Maleate | Generic | 58 | 36 | $1,238 |
| Ondansetron Hcl | Generic | 37 | 32 | $481 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 27 | 18 | $325 |
| Potassium Chloride | Generic | 23 | 0 | $1,197 |
| Ibuprofen | Generic | 20 | 0 | $272 |
| Letrozole | Generic | 18 | 0 | $591 |
| Anastrozole | Generic | 14 | 0 | $397 |
| Gabapentin | Generic | 12 | 0 | $185 |
| Olanzapine | Generic | 12 | 0 | $109 |